CancerFax

Research reports that 90% of cancers are caused by unhealthy lifestyle habits

AWritten by Alysha MendossaMedically ReviewedUpdated April 25, 20204 min read
Research reports that 90% of cancers are caused by unhealthy lifestyle habits
In this article
  1. Lifestyle Habits vs. Genetic Factors in Cancer Risk
  2. Stony Brook Study: Environmental Impact on Cancer Rates
  3. How CancerFax Helps

Lifestyle Habits vs. Genetic Factors in Cancer Risk

Medical experts say that 90% of cancer patients are caused by unhealthy life habits, not DNA plays a leading role. Diet, sunlight, smoking, and disease have a “burn-up” effect on cancer, not caused by bad DNA. Dr. Smith of the British Cancer Institute said that healthy lifestyles such as non-smoking, maintaining a healthy weight, eating healthy food and quitting alcohol cannot ensure that people do not suffer from cancer, but can significantly reduce the probability of cancer.

This suggestion is not surprising. Scientists have divided how many cases are due to people’s living habits, and how many cancer cases are inevitable. The controversy began 1 year ago, when studies reported that most cancer cases occurred due to DNA errors and occurred at random body ages and cell divisions. This means that most cancer patients are due to “bad luck” rather than unhealthy living habits.

Stony Brook Study: Environmental Impact on Cancer Rates

At present, the latest research has reached the opposite conclusion. Dr. Yusuf Hannun of Stony Brook University pointed out that although “luck” has a certain effect, people’s unhealthy living habits can seriously affect the incidence of cancer. . These unhealthy lifestyle habits include: diet, drinking, smoking, sunlight, certain viral infections, pollution, and other factors that have not yet been determined.

The research report was published in the journal Nature, and the bad genes inherited from parents are only a cause of a few cancer cases. The results of this study confirm that most cancer cases are caused by environmental factors. If these potential factors can be identified, the incidence of cancer can be controlled.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

AM

About Alysha Mendossa

✓ Reviewed for medical accuracy by the CancerFax review panel.

Medical Disclaimer

This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.

Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.